
Overview
Hideki Sumimoto practices practicing medicine in Fukuoka, Japan.
His clinical expertise encompasses Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, Cardiomyopathy, and Hearing Loss.
He is actively involved in clinical research, co-authoring 52 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hideki Sumimoto
Is Hideki Sumimoto a top-rated expert for Doxorubicin-Induced Cardiomyopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Hideki Sumimoto is classified as an Experienced expert for Doxorubicin-Induced Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hideki Sumimoto participate in research or clinical trials?
Yes. Hideki Sumimoto has published 52 articles and abstracts on conditions like Doxorubicin-Induced Cardiomyopathy. You can view a list of Hideki Sumimoto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- CardiomyopathyMr. Sumimoto isExperienced. Learn about Cardiomyopathy.
- Cardiomyopathy Due to AnthracyclinesMr. Sumimoto isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- Doxorubicin-Induced CardiomyopathyMr. Sumimoto isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.
- Hearing LossMr. Sumimoto isExperienced. Learn about Hearing Loss.